275 related articles for article (PubMed ID: 7196039)
21. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
[TBL] [Abstract][Full Text] [Related]
22. Some central effects of opioid antagonists. Part I.
Skorupska M; Langwiński R
Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
[TBL] [Abstract][Full Text] [Related]
23. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
Georgiev V; György L; Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
[TBL] [Abstract][Full Text] [Related]
24. [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice].
Motohashi N; Nakagawara M; Semba J; Ishii K; Watanabe A; Kariya T
Yakubutsu Seishin Kodo; 1983 Sep; 3(2):67-75. PubMed ID: 6659713
[TBL] [Abstract][Full Text] [Related]
25. Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate.
Gyertyán I; Petöcz L; Bajnógel J; Szücs Z; Hegedüs M; Gyüre K; Gacsályi I; Krizsán D; Fekete MI
Arzneimittelforschung; 1989 Jul; 39(7):775-81. PubMed ID: 2551306
[TBL] [Abstract][Full Text] [Related]
26. The influence of antineoplaston A5 on the central dopaminergic structures.
Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
[TBL] [Abstract][Full Text] [Related]
27. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
Jackson DM
Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
[TBL] [Abstract][Full Text] [Related]
28. Central action of pirenzepine.
Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
[TBL] [Abstract][Full Text] [Related]
29. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
Grabowska M
Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
[TBL] [Abstract][Full Text] [Related]
30. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
31. The central action of carbamazepine as a potential antidepressant drug.
Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
[TBL] [Abstract][Full Text] [Related]
32. The central action of intraventricularly (ivc) administered propranolol and phentolamine in rat.
Kleinrok Z; Ksiazek A; Przesmycki K; Kolasa K
Pol J Pharmacol Pharm; 1975; 27(4):405-12. PubMed ID: 1166021
[TBL] [Abstract][Full Text] [Related]
33. The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat.
Timar J; Knoll B; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):659-66. PubMed ID: 2908366
[TBL] [Abstract][Full Text] [Related]
34. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
Dourish CT
Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
[TBL] [Abstract][Full Text] [Related]
35. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
Kleinrok Z; Wielosz M; Przegaliński E
Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
[TBL] [Abstract][Full Text] [Related]
36. Central action of ketotifen.
Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1981; 33(5):503-15. PubMed ID: 7335554
[TBL] [Abstract][Full Text] [Related]
37. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
Przegalinski E; Baran L; Kedrek G
Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
[TBL] [Abstract][Full Text] [Related]
38. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
Olds ME; Jacques DB; Kopyov O
Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
[TBL] [Abstract][Full Text] [Related]
39. The action of compound WA-335 on the central nervous system.
Maj J; Baran L; Sowińska H; Gancarczyk L
Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
[TBL] [Abstract][Full Text] [Related]
40. Psychopharmacological profile of dexamisole.
Przegaliński E; Bigajska K; Siwanowicz J
Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
